查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571644

美国快速门诊市场规模、份额、趋势分析报告：按业主、诊断、地区和细分市场预测，2024-2030 年

U.S. Retail Clinics Market Size, Share & Trends Analysis Report By Ownership (Retail Owned, Hospital Owned), By Diagnosis (Immunization, General Symptoms, General Screening & Examination, Injuries), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格
简介目录

美国快速门诊市场成长与趋势：

Grand View Research, Inc.的最新报告显示，到2030年，美国快速门诊市场规模预计将达到68.6亿美元。

预计2024年至2030年该市场将以9.7%的复合年增长率成长。便捷的交通和实惠的价格预计将推动美国快速门诊市场的成长。

这些机构作为提供基层医疗的替代管道，以可负担的价格提供基本医疗保健服务，减少了就诊医疗保健部门的需求。在美国，大约 10% 的急诊就诊是在急诊外接受治疗的。这可以减少您去急诊室就诊时的自付费用。

这些医疗机构通常每週 7 天开放。此外，等待时间很短并且不需要预订。诊所位于便利商店或商场内，交通便利，就诊时间灵活，方便使用。

此外，电子病历等资讯科技的引入有助于维护简化的病患记录，这些记录可以在不同的医疗保健系统之间共用。此类患者资料还可用于实施人口健康管理策略，以改善患者治疗结果，并可促进美国医疗保健从按服务收费 (FFS) 模式向基于价值的护理模式的转变。

美国快速门诊市场报告亮点

  • 到 2023 年，零售商自有细分市场将占据市场主导地位，市场占有率将达到 81.8%。 CVS Health 等公司拥有、经营和管理 MinuteClinic 诊所。
  • 2023年，免疫领域占市场最大销售份额，为25.3%。据观察，在 COVID-19 大流行期间和之后，快速门诊市场越来越受到人们疫苗接种的欢迎，因为这些诊所也提供检测设施。
  • 2023 年，东南地区的收益占有率最大，达 34.2%。这是由于该地区越来越多地使用便利的非紧急医疗服务。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章美国快速门诊市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国快速门诊市场分析工具
    • 波特的分析
    • PESTEL分析

第四章美国快速门诊市场：业主估计和趋势分析

  • 细分仪表板
  • 美国快速门诊市场：2023 年和 2030 年按所有权变化分析
  • 拥有零售店
  • 医院拥有

第五章美国快速门诊市场：按诊断估计和趋势分析

  • 细分仪表板
  • 美国快速门诊市场：2023 年和 2030 年诊断变化分析
  • 免疫
  • 常见症状
  • 受伤
  • 一般筛检和测试
  • 急性呼吸道疾病及感染疾病
  • 尿道感染
  • 耳部感染疾病
  • 扭伤、拉伤、骨折
  • 其他的

第六章美国快速门诊市场：区域估计和趋势分析

  • 2023 年及 2030 年美国快速门诊市场占有率（按地区）
  • 东南
  • 中西部
  • 西南
  • 东北
  • 西方

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • CVS Health
    • Kroger Health
    • Walgreens
    • Advocate Health Care
    • Kaiser Foundation Health Plan, Inc.
    • Walmart
    • Bellin Health Systems
    • Geisinger Health
    • Target
简介目录
Product Code: GVR-1-68038-615-8

U.S. Retail Clinics Market Growth & Trends:

The U.S. retail clinics market size is anticipated to reach USD 6.86 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.7% from 2024 to 2030. Convenient access and affordable prices are expected to boost growth of the U.S. retail clinics market.

These settings act as an alternate channel for provision of primary care and offer basic healthcare services at affordable prices, lowering the need to visit the Emergency Department. Around 10% of the visits to the emergency departments in the U.S. could be treated outside of the ED. This reduces the out-of-pocket costs paid for the visit to an ED.

These settings usually operate during all seven days of a week. In addition, they have shorter waiting duration and appointments are not mandatory. Convenience and flexibility of visit hours help people easily access clinics that are located in grocery stores, shopping malls, and other locations.

In addition, adoption of information technology, highlighted by the use of EHRs helps these settings maintain a streamlined patient record that can be shared across different healthcare systems. This patient data could also be used to implement population health management strategies, for better patient outcomes, which could ease the U.S. healthcare's transformation into a value-based care model from a fee-for-service (FFS) model.

U.S. Retail Clinics Market Report Highlights:

  • Retail owned segment dominated the market with a share of 81.8% in 2023. Companies such as CVS Health, own, operate, or provide management for its MinuteClinic clinics.
  • Immunization segment held the largest revenue share of 25.3% of the market in 2023. During and after the COVID-19 pandemic, the retail clinics market observed increasing popularity among people for vaccinations as these clinics provided the testing facilities as well.
  • The Southeast region witnessed the largest revenue share of 34.2% in 2023 owing to the increasing utilization of accessible & non-emergency healthcare services in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Retail Clinics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. U.S. Retail Clinics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. U.S. Retail Clinics Market: Ownership Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Retail Clinics Market: Ownership Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Retail Owned
    • 4.3.1. Retail Owned Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 4.4. Hospital Owned
    • 4.4.1. Hospital Owned Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)

Chapter 5. U.S. Retail Clinics Market: Diagnosis Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Retail Clinics Market: Diagnosis Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Immunization
    • 5.3.1. Immunization Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.4. General Symptoms
    • 5.4.1. General Symptoms Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.5. Injuries
    • 5.5.1. Injuries Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.6. General Screening & Examination
    • 5.6.1. General Screening & Examination Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.7. Acute Respiratory Disease & Infection
    • 5.7.1. Acute Respiratory Disease & Infection Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.8. Urinary Tract Infections
    • 5.8.1. Urinary Tract Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.9. Ear Infections
    • 5.9.1. Ear Infections Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.10. Sprains, Strains, and Fractures
    • 5.10.1. Sprains, Strains, and Fractures Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Others Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)

Chapter 6. U.S. Retail Clinics Market: Regional Estimates & Trend Analysis

  • 6.1. U.S. Retail Clinics Market Share, By Region, 2023 & 2030, USD Million
  • 6.2. Southeast
    • 6.2.1. Southeast U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 6.3. Midwest
    • 6.3.1. Midwest U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 6.4. Southwest
    • 6.4.1. Southwest U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 6.5. Northeast
    • 6.5.1. Northeast U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 6.6. West
    • 6.6.1. West U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. CVS Health
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Kroger Health
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Walgreens
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Advocate Health Care
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Kaiser Foundation Health Plan, Inc.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Walmart
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Bellin Health Systems
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Geisinger Health
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Target
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives